As the TRIUMPH Phase 3 program data is published, the adverse event profile will become more complete particularly for long-term safety, cardiovascular outcomes, and rare events that require large sample sizes to detect
This discovery has led to its endorsement as a treatment option for weight management in adults with obesity or overweight conditions, particularly those with weight-related comorbidities such as hypertension, type 2 diabetes, or high cholesterol
But with so many options available, how do you choose the right one
Semaglutide is an FDA-approved weight-loss drug
Results Patients A total of 24 patients were enrolled in the study: placebo, n = 4 (two placebo patients in each cohort)
How tirzepatide works and what makes an alternative "close" Understanding tirzepatide at the receptor level is essential for evaluating alternatives